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introduction: Compared with a genetically relevant population, short stature 
(ss) is defined as a standing height more than 2 standard deviations below the 
mean (or below the third percentile) for gender. SS is a common problem for 
children and adolescents worldwide.
the aim: This study was conducted to reveal the spectrum of the genetic 
causes of proportionate ss in Alexandria, Egypt.
Patients and Methods: A total of 120 patients with proportionate SS, (87 
girls and 33 males), ages ranging from 6 months to 15 years, selected from 
the Human Genetic Clinic, Medical Research Institute, Alexandria University, 
Egypt, were included in this study. All patients were subjected to detailed 
genetic and family history, clinical genetic examination with particular attention 
to body proportions and dysmorphic features, anthropometric measurments, 
radiological examination and chromosomal analysis.
results: Parental consanguinity was found among 60.4% of the patients. 
About 37.5% of the cases had positive family history of short stature. It was 
found that proportionate SS was due to pathologic causes in 87.5% of the cases 
and to normal growth variants as constitutional growth delay and familial short 
stature in 12.5% of the cases. Pathologic causes included fetal malformation 
syndromes (27.2%), genetically determined systemic diseases (23.3%), 
chromosomal abnormalities (20%), and endocrine disorders (17.6%). About 
25% of the studied girls had Turner syndrome.
Accurate diagnosis of SS modifies the management plan for the patient and 
allows psychological and genetic counseling for the family. Karyotype analysis 
is recommended for all girls with unexplained SS. A sensitive screening system 
and an effective referral channel to genetic centers are especially important in 
the management of SS.
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introDUction                                  
Adequate lengthening of the skeleton is 
influenced by genetic, nutritional, envi-
ronmental and hormonal factors1 Short 
stature (SS), optimally defined relative 
to the genetic endowment of the indi-
vidual, is recognized by comparing an 
individual child’s height with that of 
a large population of a similar genetic 
background and, more particularly, us-
ing the mid-parental target height.
Regardless of the genetic background, 
SS may be a sign of a wide variety of 
pathologic conditions or inherited disor-
ders. Thus accurate longitudinal growth 
assessment is a fundamental aspect of 
health maintenance in children.1,2
Short stature (SS) is defined as supine 
length for children under three years 
old, or standing height for older chil-
dren, to be below the third percentile or 
two standard deviations from the mean 
height for age of a genetically relevant 
population2,3. The prevalence of SS is 
about 3% world wide.4 
Short stature may be proportionate or 
disproportionate according to the body 
habitus. Children with disproportion-
ate SS usually have a skeletal dysplasia 
while those with proportionate SS may 
have a more generalized disorder.1,2,5
The causes of proportionate SS are het-
erogenous ranging from genetic patho-
logical causes to normal growth variants 
such as familial SS and constitutional 
delay in growth and maturation. Path-
ological causes include systemic dis-
ease, endocrine disorder, psychological 
dwarfism, genetic syndrome or a chro-
mosomal or a teratogenic disorder.4,5
Short stature should not be overlooked 
because the underlying medical condi-
tions must be detected and treated be-
fore fusion of the epiphysis.2,5
Accurate diagnosis of SS modifies the 
management plan for the patient and in-
dicates psychological as well as genetic 
counseling for the family1,3. This study 
was conducted to reveal the spectrum 
of the genetic causes of proportionate 
SS in Alexandria, Egypt. 
PatientS anD MetHoDS               
This study included 120 patients with 
proportionate short stature (87 females 
and 33 males). Ages ranged from 6 
months to 15 years. They were selected 
from the Human Genetic Clinic, Medi-
cal Research Institute, Alexandria Uni-
versity, Egypt.
All patients were subjected to detailed 
genetic and family history; including 
the child’s weight and length at birth, 
the final heights, weights and pubertal 
timing in the parents and siblings; with 
pedigree construction. Clinical genetic 
examination with particular attention to 
body proportions, dysmorphic features, 
midline defects, and systems review for 
chronic illness. Anthropometric mea-
surements were carried out according 
to Tanner et al.6 The standing height in 
children or recumbent length in infants, 
was determined and plotted on Egyptian 
control chart7. In cases, who can’t com-
pletely stand or recline (e.g. those with 
spina bifida and/or contractures) arm 
span provides a reliable alternative for 
longitudinal assessment of long bone 
growth. Head circumference and weight 
measurement are essential. Arm span to 
height ratio (around 1.0 at all ages), to-
gether with sitting height to lower body 
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segment (in newborn around 1.7, which 
gradually drops to approximately 1 by 
10-12 years and remains just below 1.0 
in adulthood) are important to confirm 
the diagnose of proportionate SS.2
Radiological examination (including 
skeletal survey and bone age examina-
tion), and chromosomal analysis using 
G-banding technique were done8.  Other 
investigations were performed when 
indicated to confirm diagnosis e.g. hor-
monal assay, urine screening, Hb elec-
trophoresis, ultrasonography, ECHO 
and CT scan. 
reSUltS                                             
This study included 120 patients (87 
females and 33 males) with proportion-
ate short stature. Ages ranged from 6 
months to 15 years. The female to male 
ratio was 2.6:1.
The studied cases were classified ac-
cording to the genetic etiology into; 
pathological SS (105 cases) and normal 
growth variants (15 cases)(Table 1).
For the group with pathological causes 
of proportionate SS, 33 cases (27.5%) 
had syndromal disorders. [19 autosom-
al dominant, 12 autosomal recessive, 
2X-L dominant]. The most frequent 
were Russell-Silver, Noonan and Seck-
el syndrome (Tables 1,2).
Twenty eight cases (23.3%) had sys-
temic diseases; 16 had mucopolysacha-
ridosis, 10 had haemoglobinopathies 
(7β thalassemia and 3 seckle cell ane-
mia) and 2 had hypophosphatemic rick-
ets. (Table 1). Patients with hypophos-
phatemic rickets were diagnosed early 
because of a positive family history, 
hypophosphatemia and elevated serum 
alkaline phosphatase with normocalce-
mia. 
Twenty four cases (20%) had chromo-
somal abnormalities (22 females and 2 
males). All females cases had Turner 
syndrome, i.e. 25.3% (22/87) of the 
studied females had Turner syndrome 
(either classical, variant or mosaic). 
The most frequent karyotype was 45, 
X detected in 10 cases. Other cases had 
mosaicism and structural abnormali-
ties of the X-chromosome. Two males 
had chromosomal aberrations; one had 
47, XXY and GHD, the other had de-
letion of short arm of chromosome 18 
with panhypopituitarism. (Tables 1,3). 
Increased chromosomal breaks was de-
tected in patients with fanconi anemia, 
and defective DNA repair after UV 
exposure was demonstrated in patients 
with De-Sanctis Cacchione syndrome.
Twenty cases (16.7%) had endocrine 
disorders. Ten had growth hormone 
deficiency [Isolated GHD (8) and pan-
hypopituitarism (2)], three had GH 
insensitivity syndrome and seven had 
congenital hypothyroidism. 
Fifteen cases (12.5%) had normal 
growth variants; 8 had constitutional 
growth delay and 7 had familial short 
stature (Table 1).
In the present study 37.5% of the cases 
had positive family history of propor-
tionate SS. The frequency of parental 
consanguinity was 60.4% (Table 4).
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table 1: Classification of the studied cases according to their genetic etiology.
genetic etiology no %





X-L hypophosphatemic rickets - 
Chromosomal disorders•	
Endocrine disorders [20]•	
Growth hormone deficiency- 














II. Normal growth variants <<15>> 12.5
Constitutional growth delay- 8
Familial short stature - 7
Total 120 100
table 2: Distribution of cases with syndromal disorders.


































Focal dermal hypoplasia-	 2 ***305600
Total 33
* MIM: Mckusick Inheritance in Man.
* Autosomal dominant [AD].
** Autosomal recessive [AR].
*** X-linked dominant [X-L].
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table 3: Distribution of cases according to 
their cytogenetic results. 
Karyotype no
Normal female 65




46,X,del (X-	 p) 2
46,XX/46,X,i(X-	 q) /45,X 2
45,X/46,X,r(X)-	 1
Normal male 31




table 4: Distribution of cases according to 






no % no %
Positive 36 37.5 58 60.4
Negative 60 62.5 38 39.6
Total *96 100 96 100
Total number after exclusion of chromosomal 
anomalies (24 cases).
DiScUSSion                                           
Short stature is a common problem for 
children and adolescents worldwide. It 
may be a disability and a cause of dis-
tress in itself. Therefore, SS is important 
and require early assessment2,9. A sensi-
tive screening system and an effective 
referral channel to genetic centers are 
specially important in the management 
of SS.9
In the present study, the female to male 
ratio was 2.6:1. Previous studies re-
ported similar findings10,11 this is due to 
the high index of suspicious of Turner 
syndrome and the awareness of the im-
portance of its early recognition and 
treatment. 
In the present study, 105 (87.5%) cases 
had genetic pathological conditions and 
15 (12.5%) had normal growth vari-
ants. Several previous studies reported 
a higher frequency of normal growth 
variants ranging from 32% to 47%.1,12 
The high frequency of genetic patho-
logical conditions in the present study 
is due to the fact that most of the re-
ferred cases to our genetic unit had ge-
netic and/or inherited disorders. 
There is a wide variety of fetal malfor-
mation syndromes associated with pro-
portionate SS, caused by single gene 
disorders. Although in most cases, the 
causes are obscure, a specific diagnosis 
of a recognizable syndrome usually can 
be made.5
Previous studies reported syndromal 
disorders as an important cause of 
pathologic SS2,5. In the present study, 
sydnromal disorders were diagnosed 
in 33 cases. The most frequent were 
Russell-Silver syndrome. Noonan Syn-
drome and Seckel syndrome. This is in 
agreement with previous studies.4,10
Many fetal malformation syndromes 
with proportionate SS are inherited as 
autosomal recessive traits5. In this study, 
12 cases had AR syndromes [Seckel 
syndrome, De-sanctis Cacchione syn-
drome, Wolfram syndrome, Fanconi 
anemia and Robinow syndrome]. The 
presence of affected sibs together with 
parental consanguinity in eight cases 
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supported AR inheritance. Robinow 
syndrome is genetically heterogenous 
condition. The detection of rib fusions 
in the studied cases confirm the diagno-
sis of autosomal recessive variant.13
In the present study, increased chromo-
somal breaks was detected in 2 cases 
with Fanconi anemia, and defective 
DNA repair after UV exposure was 
demonstrated in another 2 cases with 
De-Sanctis Cacchione Syndrome. This 
confirmed their diagnosis. This is previ-
ously reported.14,15
Other fetal malformation syndromes 
with proportionate SS usually occur 
sporadically such as Russell-Silver 
Syndrome, Cornelia de-lange syndrome 
and Rubinstein-Taybi syndrome, due to 
new mutation or submicroscopic chro-
mosomal deletion5,16. In this study, 11 
cases had Russell-Silver, Conelia de-
lange and Rubinstein-Taybi syndrome. 
Negative family history in all these cas-
es suggests new mutation.
Some malformation syndromes with 
proportionate SS are inherited as auto-
somal dominant trait5. In this study, 3 
cases had neurofibromatosis type I and 
5 cases had Noonan Syndrome. This 
has been previously reported17,18. Care-
ful clinical examination of their parents 
revealed affected parents in 4 cases, 
confirming AD inheritance, necessi-
tating genetic counseling and prenatal 
diagnosis. Two studied cases had fo-
cal dermal hypoplasia, which is an X-L 
dominant trait19. An effective multidis-
ciplinary intervention can improve the 
quality of life in these cases.
Although, most autosomal abnormali-
ties and syndromal disorders are not 
treatable in terms of final height, a de-
finitive diagnosis modifies the manage-
ment plan for the patient and indicates 
psychological and genetic counseling 
for the family5,10. Growth hormone 
therapy in children with some malfor-
mation syndromes e.g. Russell-Silver 
Syndrome and Noonan Syndrome im-
proves final height.16,18,20
Many previous studies reported sys-
temic diseases as a pathologic cause 
of SS2,3 Sixteen cases in this study had 
mucopolysaccharidosis. (MPS). Short 
stature in MPS is most probably due to 
growth hormone deficiency, low insu-
lin-like growth factor-1 and/or hypo-
thyroidism21. Enzyme replacement and 
hematopioetic stem cell transplantation 
are used to treat children with MPS.21,22
Short stature is a frequent clinical pic-
ture in haemoglobinopathices most 
probably due to dysfunction of growth 
hormone-insulin like growth factor-I 
axis23,24. In the present study, 7 patients 
had thalassemia major and 3 had sickle 
cell anemia. Recombinant growth hor-
mone therapy improves growth velocity, 
heart function and bone mineral density 
in thalassemic patients23. Two studied 
cases had X-L hypophosphatemic rick-
ets. X-L hypophosphatemic patients 
present with disproportionate SS and 
bone deformities of the lower limbs25. 
The cases detected in this study were 
early diagnosed, before development of 
bone deformities, because of the pres-
ence of similarly affected sibs. Treat-
ment with Vit D metabolites combined 
with inorganic phosphate salts improve 
linear growth as well as healing rickets 
in some patients.25
In the present study, 24 cases (20%) 
had chromosomal anomalies. Turner 
syndrome represented 25.3% (22/87) of 
the studied females. The most frequent 
Karyotype was 45, X detected in 10 cas-
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es, other cases had mosaicim and struc-
turial abnormalities of the X-chromo-
some. Previous studies revealed similar 
findings10,11,26 some girls with Turner 
syndrome especially those with mosa-
icism express few phenotypic features 
prepubertally except for SS. Therefore, 
all girls with unexplained SS have to 
be referred for genetic evaluation and 
chromosomal studies. In Turner syn-
drome, introducing growth hormone for 
SS in early childhood and osterogen by 
adolescence for pubertal development 
and prevention of osteoporosis is very 
important.27,28
In the present study, 2 males had chro-
mosomal anomalies. Moreno-Garcia 
et al reported a low frequency of chro-
mosomal anomalies among males with 
SS11. One male had Klinfelter syndrome 
and growth hormone deficiency. This is 
previously reported by Reinehr et al.29 
The other male had deletion of short 
arm of chromosome 18 together with 
panhypopituitarism. This chromosomal 
anamoly was previously reported with a 
single maxillary incisor suggesting that 
the associated pituitary insufficiency 
may be due to hypothalamic defects5.
This indicates the needs for cytogenetic 
study in all children with proportionate 
SS.
Many disturbances in the endocrine 
system can impair linear growth1,2. In 
the present study. Twenty cases (16.7%) 
had endocrine disorders. The common-
est was growth hormone deficiency 
(GHD). This is in agreement with previ-
ous studies1,3,30. In the present study, 10 
cases had GHD [8 had isolated GHD, 2 
had panhypopituitarism] and 3 had GH 
resistance syndrome. The basic defect 
in GH resistance syndrome is abnormal 
or deficient GH receptors31. Referral 
to a pediatric endocrinologist may be 
appropriate as GH replacement is nec-
essary. Congenital hypothyroidism is 
one of the most common preventable 
causes of mental retardation32. In the 
present study, 7 cases had congenital 
hypothyroidism, four of them had pa-
rental consanguinity and affected sibs. 
This is most probably due to an auto-
somal recessive inborn error in thyroid 
hormone synthesis. Newborn screening 
programme is important to allow early 
detection and treatment.32
In the present study, normal growth 
variants were diagnosed in 15 cases (8 
had constitutional growth delay and 7 
had familial SS). All had positive fam-
ily history of SS and/or delayed pu-
berty. In adolescent with constitutional 
growth delay, and severe psychological 
distress, hormone therapy to accelerate 
puberty may be appropriate33. Careful 
clinical examination of parents in cases 
suggestive of familial SS is very impor-
tant because some of the pathological 
causes of SS are inheritable.
In the present study, 60.4% of the cas-
es had consanguineous parents, which 
is higher than the general population 
(28.9%)34. The association of parental 
consanguinity and genetic disorders 
was proved in previous studies1,35. This 
could explain the presence of different 
inheritable disorders with proportionate 
SS in this study. Genetic counseling is 
highly recommended in these families.
conclUSion                                        
This study highlighted the genetic eti-
ologies of proportionate SS. Syndromal 
disorders, systemic diseases and chro-
mosomal disorders are the most fre-
quent genetic causes of proportionate 
SS in Alexandria, Egypt. Increased pa-
rental consanguinity and positive family 
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history in cases with SS necessitate ge-
netic counseling to the public. Careful 
clinical examination of parents in cases 
suggestive of familial SS is very impor-
tant. Chromosomal analysis should be 
done to all girls with unexplained SS. 
Genetic evaluation of cases with SS is 
necessary to reach accurate diagnosis 
allowing proper management and ge-
netic counseling to the patient and his 
family. A collaborative study to acertain 
all causes of SS in the general popula-
tion should be performed in order to 
delineate the complete picture in short 
stature of children living in Egypt.
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